Skip to main content
Premium Trial:

Request an Annual Quote

Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents

NEW YORK – Natera has sued Progenity, alleging that the molecular diagnostics firm's noninvasive prenatal Innatal test infringes six of its patents.

The suit comes shortly after Progenity filed for an initial public offering in which it is seeking to raise up to $122.6 million.

In its complaint, filed on Wednesday with the US District Court for the Western District of Texas, Waco Division, Natera claims that the use and sale of Progenity's Innatal Prenatal Screen test infringes six of its patents: US Patents 9,228,234 and 10,522,242, both titled "Methods for noninvasive prenatal ploidy calling"; US Patents 9,424,392, 10,227,652, and 10,240,202, all titled "System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals;" and US Patent 10,266,893, titled "System and method for cleaning noisy genetic data and determining chromosome copy number."

Natera is seeking injunctive relief, monetary damages, court expenses, and a jury trial.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.